These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17589545)

  • 1. How Ebola and Marburg viruses battle the immune system.
    Mohamadzadeh M; Chen L; Schmaljohn AL
    Nat Rev Immunol; 2007 Jul; 7(7):556-67. PubMed ID: 17589545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
    Jones SM; Feldmann H; Ströher U; Geisbert JB; Fernando L; Grolla A; Klenk HD; Sullivan NJ; Volchkov VE; Fritz EA; Daddario KM; Hensley LE; Jahrling PB; Geisbert TW
    Nat Med; 2005 Jul; 11(7):786-90. PubMed ID: 15937495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single shot against Ebola and Marburg virus.
    Baize S
    Nat Med; 2005 Jul; 11(7):720-1. PubMed ID: 16015361
    [No Abstract]   [Full Text] [Related]  

  • 4. Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.
    Warfield KL; Swenson DL; Negley DL; Schmaljohn AL; Aman MJ; Bavari S
    Vaccine; 2004 Sep; 22(25-26):3495-502. PubMed ID: 15308377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
    Swenson DL; Warfield KL; Negley DL; Schmaljohn A; Aman MJ; Bavari S
    Vaccine; 2005 Apr; 23(23):3033-42. PubMed ID: 15811650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
    Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses.
    Grant-Klein RJ; Altamura LA; Schmaljohn CS
    Virus Res; 2011 Dec; 162(1-2):148-61. PubMed ID: 21925552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccines for biodefense.
    Dupuy LC; Schmaljohn CS
    Expert Rev Vaccines; 2009 Dec; 8(12):1739-54. PubMed ID: 19943766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune evasion by filoviruses.
    Basler CF
    Virology; 2015 May; 479-480():122-30. PubMed ID: 25843618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
    Suschak JJ; Schmaljohn CS
    Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marburg and Ebola--arming ourselves against the deadly filoviruses.
    Peters CJ
    N Engl J Med; 2005 Jun; 352(25):2571-3. PubMed ID: 15972860
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.
    Bausch DG; Sprecher AG; Jeffs B; Boumandouki P
    Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid assembly of sensitive antigen-capture assays for Marburg virus, using in vitro selection of llama single-domain antibodies, at biosafety level 4.
    Sherwood LJ; Osborn LE; Carrion R; Patterson JL; Hayhurst A
    J Infect Dis; 2007 Nov; 196 Suppl 2():S213-9. PubMed ID: 17940952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good news for Marburg virus workers.
    Becker S
    Lancet; 2006 Apr; 367(9520):1373-4. PubMed ID: 16650630
    [No Abstract]   [Full Text] [Related]  

  • 15. [Monoclonal antibodies to Ebola virus: isolation, characteristics, and study of cross reactivity with Marburg virus].
    Kazachinskaia EI; Pereboev AV; Chepurnov AA; Belanov EF; Razumov IA
    Vopr Virusol; 2000; 45(3):40-4. PubMed ID: 10867995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecology of Marburg and Ebola viruses: speculations and directions for future research.
    Monath TP
    J Infect Dis; 1999 Feb; 179 Suppl 1():S127-38. PubMed ID: 9988176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses.
    Mohamadzadeh M; Coberley SS; Olinger GG; Kalina WV; Ruthel G; Fuller CL; Swenson DL; Pratt WD; Kuhns DB; Schmaljohn AL
    J Virol; 2006 Jul; 80(14):7235-44. PubMed ID: 16809329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebolavirus and Marburgvirus: insight the Filoviridae family.
    Ascenzi P; Bocedi A; Heptonstall J; Capobianchi MR; Di Caro A; Mastrangelo E; Bolognesi M; Ippolito G
    Mol Aspects Med; 2008 Jun; 29(3):151-85. PubMed ID: 18063023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marburg and Ebola viruses as aerosol threats.
    Leffel EK; Reed DS
    Biosecur Bioterror; 2004; 2(3):186-91. PubMed ID: 15588056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever.
    Grolla A; Lucht A; Dick D; Strong JE; Feldmann H
    Bull Soc Pathol Exot; 2005 Sep; 98(3):205-9. PubMed ID: 16267962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.